Related Experiment Video
Updated: Jan 28, 2026
07:16
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
14.6K
New markers in prostate cancer: Genomics
Susanne Fuessel1, Manfred P Wirth1
1Department of Urology. University Hospital and Faculty of Medicine. Technische Universität Dresden. Dresden. Germany. National Center for Tumor Diseases (NCT), partner site Dresden. Dresden. Germany.
Archivos Espanoles De Urologia
|March 12, 2019
Summary
Genomic biomarkers show promise for improving prostate cancer (PCa) detection and predicting tumor aggressiveness. These molecular markers could enhance diagnostic accuracy and guide treatment decisions for better patient outcomes.
Area of Science:
- Oncology
- Genetics
- Biomarker Discovery
Background:
- Prostate cancer (PCa) heterogeneity complicates outcome prediction at diagnosis.
- Current methods like Gleason grading and PIRADS MRI have limitations in accurately stratifying PCa patient risk.
- There is a need for more precise tools to predict disease course and guide therapeutic decisions.
Purpose of the Study:
- To review current literature on genomic biomarkers for PCa detection and early aggressiveness prediction.
- To assess the utility of germline mutations, SNPs, and other molecular markers in PCa diagnostics.
- To evaluate the clinical applicability of genomic biomarker assays in risk stratification and treatment planning.
Main Methods:
- Literature review of genomic biomarkers for PCa.
- Discussion of germline mutations and single nucleotide polymorphisms (SNPs) influencing PCa onset.
- Review of urine- and tissue-based tests analyzing genetic, epigenetic, and transcriptional alterations.
Main Results:
- Genomic biomarker assays, validated in large cohorts, show potential clinical usability.
- These assays aid in screening men at risk and in re-evaluating negative biopsies with persistent suspicion.
- Several assays can identify high-risk PCa patients for treatment or active surveillance selection.
Conclusions:
- Genomic biomarkers offer a promising avenue for improving PCa diagnostics and risk stratification.
- Further prospective studies are needed to confirm the clinical utility and facilitate the adoption of these assays in practice.
- Genomic markers may lead to more personalized management strategies for prostate cancer patients.
Related Concept Videos
02:02Genomics
40.3K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
40.3K
02:30Genomic Imprinting and Inheritance
37.1K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
37.1K
03:21Genome Size and the Evolution of New Genes
9.1K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
9.1K
02:16Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
15.9K
The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
15.9K
00:46Genomic DNA in Prokaryotes
48.5K
The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Genomic Diversity in Bacteria
Although bacterial genomes are much...
48.5K
00:58Genomic DNA in Eukaryotes
52.8K
Eukaryotes have large genomes compared to prokaryotes. To fit their genomes into a cell, eukaryotic DNA is packaged extraordinarily tightly inside the nucleus. To achieve this, DNA is tightly wound around proteins called histones, which are packaged into nucleosomes that are joined by linker DNA and coil into chromatin fibers. Additional fibrous proteins further compact the chromatin, which is recognizable as chromosomes during certain phases of cell division.
52.8K